Home » Stocks » Cellect Biotechnology

Cellect Biotechnology Ltd. (APOP)

Stock Price: $3.30 USD -0.07 (-2.08%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 11.14M
Revenue (ttm) n/a
Net Income (ttm) -4.80M
Shares Out 3.38M
EPS (ttm) -0.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $3.30
Previous Close $3.37
Change ($) -0.07
Change (%) -2.08%
Day's Open 3.35
Day's Range 3.21 - 3.35
Day's Volume 82,776
52-Week Range 0.40 - 6.89

More Stats

Market Cap 11.14M
Enterprise Value 6.27M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 3.38M
Float 2.08M
EPS (basic) n/a
EPS (diluted) -0.85
FCF / Share -0.03
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 14,923
Short Ratio 0.05
Short % of Float n/a
Beta 2.39
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 1.78
Revenue n/a
Operating Income -6.38M
Net Income -4.80M
Free Cash Flow -5.84M
Net Cash 4.87M
Net Cash / Share 1.44
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -38.18%
ROE -65.02%
ROIC 2,165.00%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$3.00*
Low
3.00
Current: $3.30
High
3.00
Target: 3.00
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions ILS.

Financial Overview

Year2019201820172016201520142013
Revenue-------
Operating Income-22.33-29.25-24.43-15.94-10.10-5.55-3.49
Net Income-16.81-20.11-28.22-15.32-10.17-5.55-3.68
Shares Outstanding21312911218.2314.9013.199.83
Earnings Per Share-0.08-0.16-0.25-0.84-0.69-0.42-0.38
Operating Cash Flow-20.34-23.64-17.77-14.41-7.71-4.40-2.63
Capital Expenditures-0.12-0.66-0.27-1.17-0.26-0.23-0.02
Free Cash Flow-20.45-24.29-18.04-15.58-7.97-4.63-2.65
Cash & Equivalents18.1117.8127.7330.9411.7413.380.00
Total Debt1.07------
Net Cash / Debt17.0317.8127.7330.9411.7413.380.00
Assets21.3220.6430.3733.9113.3613.79-
Liabilities6.486.7211.525.422.860.84-
Book Value14.8413.9218.8528.4910.5012.96-
Numbers in millions ILS, except per-share numbers.

Company Profile

Company Details

Full Name Cellect Biotechnology Ltd.
Country Israel
Employees 14
CEO Shai Yarkoni

Stock Information

Ticker Symbol APOP
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: APOP

Description

Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. It is developing the ApoTainer selection kit, a shelf stem cell selection kit for allogeneic hematopoietic stem cell transplantation procedures for patients suffering from hematological malignancies. The company has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; and Cell2in Inc. to conduct scientific evaluations combining ApoGraft with Cell2in's identification technology FreSHtracer, which monitors stem cell quality by utilizing a fluorescent dye to characterize their oxidative stress state. It also has a collaboration with the Washington University School of Medicine to determine the safety and tolerability of ApoGraft for bone marrow transplantations in the United States. The company was formerly known as Cellect Biomed Ltd. and changed its name to Cellect Biotechnology Ltd. in July 2016. Cellect Biotechnology Ltd. was founded in 2011 and is headquartered in Kfar Saba, Israel.